Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1644055

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1644055

Pharma 4.0

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Pharma 4.0 Market to Reach US$40.3 Billion by 2030

The global market for Pharma 4.0 estimated at US$13.7 Billion in the year 2024, is expected to reach US$40.3 Billion by 2030, growing at a CAGR of 19.7% over the analysis period 2024-2030. Pharma 4.0 Software, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$21.9 Billion by the end of the analysis period. Growth in the Pharma 4.0 Services segment is estimated at 22.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 18.7% CAGR

The Pharma 4.0 market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 18.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.8% and 17.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Pharma 4.0 Market - Key Trends & Drivers Summarized

What Is Pharma 4.0 and How Is It Revolutionizing the Pharmaceutical Industry?

Pharma 4.0 represents a paradigm shift in the pharmaceutical industry, leveraging advanced technologies such as artificial intelligence (AI), machine learning (ML), Internet of Things (IoT), and blockchain to create a connected, intelligent, and automated ecosystem. Rooted in the principles of Industry 4.0, Pharma 4.0 aims to modernize pharmaceutical manufacturing and operations, ensuring enhanced efficiency, compliance, and quality control. The framework integrates smart manufacturing, digitalized supply chains, and predictive analytics to enable real-time decision-making and greater agility in production processes. Pharma 4.0 also addresses the growing need for personalized medicine, enabling precise and efficient drug production tailored to individual patient needs. As global healthcare systems face increasing demands for cost-effective solutions and faster time-to-market for new drugs, Pharma 4.0 is rapidly becoming the cornerstone of innovation in the pharmaceutical sector.

How Are Technological Advancements Shaping the Adoption of Pharma 4.0?

The adoption of Pharma 4.0 has been significantly accelerated by advancements in enabling technologies. AI and ML are at the forefront, driving predictive maintenance in manufacturing equipment, optimizing production schedules, and identifying potential quality issues before they escalate. IoT and sensor technologies enable real-time monitoring of production environments, ensuring precise control over variables such as temperature and humidity. Blockchain technology enhances supply chain transparency and security, enabling traceability of pharmaceutical products from raw materials to end-users. Cloud computing and data analytics platforms facilitate seamless integration and analysis of large volumes of data, empowering pharmaceutical companies to make data-driven decisions. Furthermore, digital twins—virtual replicas of physical processes—allow for testing and optimization of manufacturing systems without disrupting actual production, thereby reducing downtime and costs.

Which Industries and Stakeholders Are Driving the Adoption of Pharma 4.0?

Pharma 4.0 adoption is being led by pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and regulatory bodies. Manufacturers are leveraging these technologies to modernize facilities, reduce waste, and enhance productivity. CDMOs, which play a critical role in outsourced drug production, are integrating Pharma 4.0 solutions to meet client demands for efficient and compliant processes. Regulatory bodies such as the FDA and EMA are encouraging the adoption of digital technologies to improve compliance and traceability. In addition, the push for personalized medicine and biologics has created a surge in demand for flexible manufacturing systems that Pharma 4.0 enables. Key applications include process automation, real-time quality assurance, and predictive maintenance. The increasing complexity of pharmaceutical products and the need for end-to-end traceability are further driving the adoption of Pharma 4.0 solutions across the value chain.

What Are the Key Drivers Fueling the Growth of the Pharma 4.0 Market?

The growth in the Pharma 4.0 market is driven by several factors, including advancements in technology, evolving regulatory frameworks, and changing industry needs. The rising demand for personalized and precision medicines has prompted pharmaceutical companies to adopt flexible and automated manufacturing systems enabled by Pharma 4.0. Increasing regulatory requirements for traceability and compliance are compelling firms to integrate blockchain and IoT solutions. Additionally, the growing prevalence of complex biologics and biosimilars necessitates advanced quality control measures, which are achievable through AI-driven analytics. The shift toward data-driven decision-making, coupled with the rising adoption of cloud and edge computing, has further accelerated market growth. Furthermore, the push for sustainability and energy efficiency in pharmaceutical manufacturing is driving demand for smart, resource-optimized production systems. The increasing collaboration between technology providers and pharmaceutical companies, along with rising investments in digital transformation, is ensuring steady growth in the Pharma 4.0 market.

SCOPE OF STUDY:

The report analyzes the Pharma 4.0 market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Pharma 4.0 Software, Pharma 4.0 Services); Technology (Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology, Other Technologies); Application (Drug Discovery & Development Application, Manufacturing Application, Supply Chain Management Application, Other Applications); End-Use (Pharma & Biotech Companies End-Use, CRO & CDMO End-Use, Healthcare Providers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 25 Featured) -

  • Amazon Web Services, Inc.
  • Aspen Technology, Inc.
  • Cisco Systems, Inc.
  • GE Healthcare
  • IBM Corporation
  • Lighthouse Worldwide Solutions Inc.
  • nexocode
  • Oracle Corporation
  • Tulip Interfaces, Inc.
Show more
Product Code: MCP32549

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Pharma 4.0 - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Adoption of Smart Manufacturing Systems in Pharmaceuticals Propels Growth
    • Increasing Use of IoT for Real-Time Monitoring Drives Pharma 4.0 Adoption
    • AI and Machine Learning Enable Predictive Quality Control, Fueling Demand
    • Expansion of Continuous Manufacturing Processes Enhances Market Potential
    • Integration of Blockchain in Pharma Supply Chains Boosts Market Growth
    • Digital Twins for Drug Development Propel Pharma 4.0 Deployment
    • Advancements in Robotics Drive Efficiency in Pharmaceutical Manufacturing
    • Rising Demand for Personalized Medicine Fuels Adoption of Pharma 4.0 Technologies
    • Increased Focus on Data Analytics Improves Decision-Making in Pharma Operations
    • Expansion of Cloud-Based Pharma Solutions Drives Market Growth
    • AR and VR Technologies Revolutionize Pharma Training and Operations
    • Predictive Maintenance Enhances Equipment Management Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pharma 4.0 Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pharma 4.0 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pharma 4.0 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Pharma 4.0 Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Pharma 4.0 Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Pharma 4.0 Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Pharma 4.0 Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Supply Chain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Manufacturing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Manufacturing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for CRO & CDMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for CRO & CDMO End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Artificial Intelligence & Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Artificial Intelligence & Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Big Data Analytics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Big Data Analytics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for IoT Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for IoT Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Blockchain Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Blockchain Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Pharma 4.0 by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pharma 4.0 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Pharma 4.0 by Component - Pharma 4.0 Software and Pharma 4.0 Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Pharma 4.0 by Component - Percentage Breakdown of Value Sales for Pharma 4.0 Software and Pharma 4.0 Services for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Pharma 4.0 by Application - Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Pharma 4.0 by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Other Applications, Drug Discovery & Development Application and Manufacturing Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Pharma 4.0 by End-Use - Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Pharma 4.0 by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CRO & CDMO End-Use and Healthcare Providers End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Pharma 4.0 by Technology - Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Pharma 4.0 by Technology - Percentage Breakdown of Value Sales for Artificial Intelligence & Machine Learning Technology, Big Data Analytics Technology, IoT Technology, Blockchain Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!